UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Chronological sequences and blood-brain barrier permeability changes in local injury as assessed by nuclear magnetic resonance (NMR) images from sliced rat brain

Stroke (1970), 1983-03, Vol.14 (2), p.191-197

1983

Volltextzugriff (PDF)

Nuclear magnetic resonance (NMR) imaging of brain edema from sliced rat brain: preliminary report

No To Shinkei, 1982-09, Vol.34 (9), p.881

1982

Volltextzugriff (PDF)

Germline gain-of-function mutations in RAF1 cause Noonan syndrome

Nature genetics, 2007-08, Vol.39 (8), p.1013-1017

2007

Volltextzugriff (PDF)

Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population

Japanese journal of clinical oncology, 2010-06, Vol.40 (6), p.508-512

2010

Volltextzugriff (PDF)

Response to primary treatment for first recurrence independently influences survival of patients with hormone receptor-positive, HER2-negative breast cancer: A multicenter study of 236 recurrent metastatic patients

Annals of oncology, 2018-10, Vol.29, p.viii112-viii112

2018

Volltextzugriff (PDF)

Local recurrence risk after previous salvage mastectomy

European journal of surgical oncology, 2016-07, Vol.42 (7), p.980-985

2016

Volltextzugriff (PDF)

Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis

European journal of surgical oncology, 2016-04, Vol.42 (4), p.474-480

2016

Volltextzugriff (PDF)

399 (PB-032) - Beneficial factors in the therapeutic strategy following initial endocrine therapy for first distant recurrence of breast cancer in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative cancer

European journal of cancer (1990), 2018-04, Vol.92, p.S115-S115

2018

Volltextzugriff (PDF)

Beneficial factors in the therapeutic strategy following initial endocrine therapy for first distant recurrence of breast cancer in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative cancer

European journal of cancer (1990), 2018-04, Vol.92, p.S115

2018

Volltextzugriff (PDF)

Single nucleotide variations in CLCN6 identified in patients with benign partial epilepsies in infancy and/or febrile seizures

PloS one, 2015-03, Vol.10 (3), p.e0118946-e0118946

2015

Volltextzugriff (PDF)

329 (PB-124) - PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy

European journal of cancer (1990), 2018-04, Vol.92, p.S91-S91

2018

Volltextzugriff (PDF)

PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy

European journal of cancer (1990), 2018-04, Vol.92, p.S91

2018

Volltextzugriff (PDF)

P223 - Factors influencing prognosis in elderly women with breast cancer

Breast (Edinburgh), 2019-03, Vol.44, p.S92-S92

2019

Volltextzugriff (PDF)

Factors influencing prognosis in elderly women with breast cancer

Breast (Edinburgh), 2019-03, Vol.44, p.S92

2019

Volltextzugriff (PDF)

353P - Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study

Annals of oncology, 2019-10, Vol.30, p.v127-v128

2019

Volltextzugriff (PDF)

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study

Annals of oncology, 2019-10, Vol.30, p.v127-v128

2019

Volltextzugriff (PDF)

353PPertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence

European journal of surgical oncology, 2015-04, Vol.41 (4), p.548-552

2015

Volltextzugriff (PDF)

342PResponse to primary treatment for first recurrence independently influences survival of patients with hormone receptor-positive, HER2-negative breast cancer: A multicenter study of 236 recurrent metastatic patients

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Abstract OT2-06-02: A randomized phase II study of maintenance hormone therapy with or without capecitabine after induction therapy with bevacizumab plus paclitaxel in hormone receptor positive and HER2 negative metastatic breast cancer (KBCSG-TR1214)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT2-06-02-OT2-06-02

2018

Volltextzugriff (PDF)

Abstract GS3-04: A prospective randomized multi-center open-label phase III trial of extending aromatase-inhibitor adjuvant therapy to 10 years - Results from 1697 postmenopausal women in the N-SAS BC 05 trial: Arimidex extended adjuvant randomized study (AERAS)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS3-04-GS3-04

2019

Volltextzugriff (PDF)

TULIP1 ( RALGAPA1) haploinsufficiency with brain development delay

Genomics (San Diego, Calif.), 2009-12, Vol.94 (6), p.414-422

2009

Volltextzugriff (PDF)

Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice

The Journal of pharmacology and experimental therapeutics, 2001-06, Vol.297 (3), p.1160

2001

Volltextzugriff (PDF)

Preferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patients

Patient preference and adherence, 2013-01, Vol.7 (default), p.1201-1206

2013

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(72)
Tagungsberichte
(1)

Sprache

Englisch
(69)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(8)
Annals Of Oncology
(5)
European Journal Of Cancer
(5)
Breast
(4)
Anticancer Research
(3)
European Journal Of Surgical Oncology
(3)
Gastroenterology
(3)
Physics Letters. B
(3)
Sangyo Igaku
(3)
Sangyou Igaku/sangyo Igaku
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chronological sequences and blood-brain barrier permeability changes in local injury as assessed by nuclear magnetic resonance (NMR) images from sliced rat brain

Nuclear magnetic resonance (NMR) imaging of brain edema from sliced rat brain: preliminary report

Germline gain-of-function mutations in RAF1 cause Noonan syndrome

Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population

Response to primary treatment for first recurrence independently influences survival of patients with hormone receptor-positive, HER2-negative breast cancer: A multicenter study of 236 recurrent metastatic patients

Local recurrence risk after previous salvage mastectomy

Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis

399 (PB-032) - Beneficial factors in the therapeutic strategy following initial endocrine therapy for first distant recurrence of breast cancer in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative cancer

Beneficial factors in the therapeutic strategy following initial endocrine therapy for first distant recurrence of breast cancer in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative cancer

Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer : Risk factors and impact on distant metastases

Single nucleotide variations in CLCN6 identified in patients with benign partial epilepsies in infancy and/or febrile seizures

329 (PB-124) - PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy

PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy

P223 - Factors influencing prognosis in elderly women with breast cancer

Factors influencing prognosis in elderly women with breast cancer

353P - Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study

353PPertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer: Results of single arm phase IV COMACHI study

Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence

342PResponse to primary treatment for first recurrence independently influences survival of patients with hormone receptor-positive, HER2-negative breast cancer: A multicenter study of 236 recurrent metastatic patients

Abstract OT2-06-02: A randomized phase II study of maintenance hormone therapy with or without capecitabine after induction therapy with bevacizumab plus paclitaxel in hormone receptor positive and HER2 negative metastatic breast cancer (KBCSG-TR1214)

Abstract GS3-04: A prospective randomized multi-center open-label phase III trial of extending aromatase-inhibitor adjuvant therapy to 10 years - Results from 1697 postmenopausal women in the N-SAS BC 05 trial: Arimidex extended adjuvant randomized study (AERAS)

TULIP1 ( RALGAPA1) haploinsufficiency with brain development delay

Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice

Preferences for oral versus intravenous adjuvant chemotherapy among early breast cancer patients

Suchergebnisse filtern